319 studies found for:    Osteosarcoma
Show Display Options
Rank Status Study
21 Recruiting Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: High Dose Methotrexate
22 Unknown  Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Zoledronic acid;   Drug: Standard chemotherapy
23 Terminated A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response
Conditions: Osteosarcoma;   Lung Metastases
Interventions: Drug: Dexrazoxane;   Drug: Doxorubicin;   Drug: Cisplatin;   Drug: G-CSF;   Drug: PEG-filgrastim;   Drug: Etoposide;   Drug: Ifosfamide;   Drug: Mesna;   Drug: Leucovorin
24 Recruiting Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
Condition: Pulmonary Relapse of Osteosarcoma
Intervention: Drug: Inhaled Lipid Cisplatin (ILC)
25 Not yet recruiting Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Radiation: heavy ion radiotherapy (C12)
26 Unknown  Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma
Condition: Osteosarcoma
Interventions: Dietary Supplement: Curcumin powder;   Dietary Supplement: Ashwagandha extract
27 Completed Sorafenib in Relapsed High Grade Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: sorafenib
28 Recruiting Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Conditions: Osteosarcoma;   Nephrotoxicity;   Ototoxicity
Interventions: Drug: Pantoprazole;   Drug: High-dose methotrexate infusion duration
29 Recruiting Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Conditions: Adult Alveolar Soft-part Sarcoma;   Adult Angiosarcoma;   Adult Desmoplastic Small Round Cell Tumor;   Adult Epithelioid Hemangioendothelioma;   Adult Epithelioid Sarcoma;   Adult Extraskeletal Chondrosarcoma;   Adult Extraskeletal Osteosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Liposarcoma;   Adult Malignant Fibrous Histiocytoma;   Adult Malignant Mesenchymoma;   Adult Neurofibrosarcoma;   Adult Rhabdomyosarcoma;   Adult Synovial Sarcoma;   Chondrosarcoma;   Clear Cell Sarcoma of the Kidney;   Conjunctival Kaposi Sarcoma;   Dermatofibrosarcoma Protuberans;   Gastrointestinal Stromal Tumor;   Metastatic Adult Malignant Fibrous Histiocytoma of Bone;   Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Metastatic Osteosarcoma;   Ovarian Sarcoma;   Recurrent Adult Malignant Fibrous Histiocytoma of Bone;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Kaposi Sarcoma;   Recurrent Osteosarcoma;   Recurrent Uterine Sarcoma;   Small Intestine Leiomyosarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Uterine Sarcoma
Interventions: Drug: vismodegib;   Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097;   Other: laboratory biomarker analysis;   Other: pharmacological study
30 Recruiting ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Mifamurtide arm;   Other: 3 drugs arm
31 Completed Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma
Conditions: Metastatic Osteosarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Osteosarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Biological: cixutumumab;   Drug: temsirolimus;   Other: laboratory biomarker analysis
32 Completed Inhalation SLIT Cisplatin for the Treatment of Osteosarcoma Metastatic to the Lung
Condition: Osteosarcoma
Intervention: Drug: SLIT Cisplatin
33 Active, not recruiting Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients
Condition: Osteosarcoma
Intervention:
34 Active, not recruiting A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Condition: Osteosarcoma
Interventions: Drug: Saracatinib;   Drug: Placebo
35 Completed
Has Results
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
Conditions: Bone Cancer;   Chondrosarcoma;   Clear Cell Sarcoma of the Kidney;   Metastatic Osteosarcoma;   Ovarian Sarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Osteosarcoma;   Recurrent Uterine Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Uterine Sarcoma
Interventions: Drug: therapeutic angiotensin-(1-7);   Other: laboratory biomarker analysis
36 Recruiting To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Conditions: Neuroblastoma;;   Rhabdomyosarcoma;;   Ewing's Sarcoma;;   Ewing's Tumor;;   Sarcoma, Ewing's;;   Sarcomas, Epitheliod;;   Sarcoma, Soft Tissue;;   Sarcoma, Spindle Cell;;   Melanoma;;   Malignant Melanoma;;   Clinical Oncology;;   Oncology, Medical;;   Pediatrics, Osteosarcoma;;   Osteogenic Sarcoma;;   Osteosarcoma Tumor;;   Sarcoma, Osteogenic;;   Tumors;;   Cancer;;   Neoplasia;;   Neoplasm;;   Histiocytoma;;   Fibrosarcoma;;   Dermatofibrosarcoma
Intervention: Drug: nab-paclitaxel
37 Active, not recruiting Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Other: laboratory biomarker analysis
38 Active, not recruiting Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Mifamurtide
39 Completed Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Mifamurtide (L-MTP-PE)
40 Not yet recruiting Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Lithium Carbonate

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years